Dialysis Biocompatibility and Phagocytic Cell Function

Himmelfarb, Jonathan

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29DK045610-03
• Application #: 2144822
• Study Section: Surgery and Bioengineering Study Section (SB)
• Project Start: 1994-01-01
• Project End: 1998-12-31
• Budget Start: 1996-02-01
• Budget End: 1996-12-31
• Support Year: 3
• Fiscal Year: 1996

Institution

• Name: Maine Medical Center
• City: Portland
• State: ME
• Country: United States
• Zip Code: 04102

Publications

Becker, B N; Himmelfarb, J; Henrich, W L et al. (1997) Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8:475-86

Himmelfarb, J; McMonagle, E; Holbrook, D et al. (1995) Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med 126:392-400